Controlled Drug Release Systems for Cerebrovascular Diseases
Abstract This review offers a comprehensive exploration of optimized drug delivery systems tailored for controlled release and their crucial role in addressing cerebrovascular diseases. Through an in‐depth analysis, various controlled release methods, including nanoparticles, liposomes, hydrogels, and other emerging technologies are examined. Highlighting the importance of precise drug targeting, it is delved into the underlying mechanisms of these delivery systems and their potential to improve therapeutic outcomes while minimizing adverse effects. Additionally, the specific applications of these optimized drug delivery systems in treating cerebrovascular disorders such as ischemic stroke, cerebral aneurysms, and intracranial hemorrhage are discussed. By shedding light on the advancements in drug delivery techniques and their implications in cerebrovascular medicine, this review offers valuable insights into the future of therapeutic interventions in neurology.
Authors
- María Victoria Gómez‐Gaviro (ORCID: https://orcid.org/0000-0002-8683-5150)
- Sofia Caspani (ORCID: https://orcid.org/0000-0002-1996-768X)
- C. T. Sousa (ORCID: https://orcid.org/0000-0003-2879-0051)
- Manuel Desco (ORCID: https://orcid.org/0000-0003-0989-3231)
- Celia Martín‐Morales
Institutions
- Universidade do Porto (PT)
- Spanish National Centre for Cardiovascular Research (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Universidad Carlos III de Madrid (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Advanced Therapeutics
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1002/adtp.202400239
- Citations
- 3
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.52
Funders
- Comunidad de Madrid
- Centro Nacional de Investigaciones Cardiovasculares
- Agencia Estatal de Investigación